COMMITMENTS AND CONTINGENCIES (Details Narrative)	12 Months Ended
	Dec. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2024 AUD ($)	Dec. 31, 2024 AUD ($)
Property, Plant and Equipment [Line Items]
Accrued liabilities	$ 237,505	$ 735,098
Accounts payable	581,020	521,747
Research and development expenses	2,781,017	2,841,272
Research and development expense tax credit receivable
Research and development tax credit		290,447
Future cash	4,677,491	2,241,026
Other Consulting and Vendor Agreements [Member]
Property, Plant and Equipment [Line Items]
Future cash	400,000
Avance Clinical [Member]
Property, Plant and Equipment [Line Items]
Contract cost		2,114,000		$ 3,400,000
Total project costs			$ 3,300,000
Prepaid assets		0
Accrued liabilities		0
Accounts payable		0
Research and development expenses	$ 0	$ 495,465